IRON-DEFICIENCY ANEMIA IN PREGNANCY: PECULIARITIES OF THERAPY
https://doi.org/10.21518/2079-701X-2017-20-194-197
Abstract
Anemia is common in women during pregnancy and in the postpartum period. This disorder is caused by the physiologically increasing needs of the fetus and often initially reduced iron stores in the mother’s body. Iron deficiency can underlie a number of complications of the gestation period for both the woman and the newborn at a later time. The fastest, most effective and safe management of iron deficiency anemia, especially in its severe forms, allows avoiding complications and improving pregnancy outcomes. Administration of iron supplements is the main method of management of iron deficiency anemia. However, oral forms do not allow achieving the effect in all cases, taking into account the peculiarities of iron absorption from the GI tract. Ferric carboxymaltose is an intravenous drug that has good tolerability and, what is most importantly, effectively and quickly replenishes iron deficiency in pregnant women starting from the second trimester and in the postpartum period.
About the Author
M. A. Vinogradova
Kulakov Scientific Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health.
Russian Federation
Russian Federation
PhD in medicine.
Moscow.
References
1. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol, 2016 Jan, 91(1): 31-38.
2. Achebe ММ and Gafter-Gvili А How I treat anemia in pregnancy: iron, cobalamin, and folate. BLOOD, 2017 Feb 23, 129(8): 940-949
3. Виноградова М.А., Федорова Т.А., Рогачевский О.В. Анемия при беременности: алгоритмы диагностики и лечения железодефицита. Акушерство и гинекология, 2014, 8: 138-143.
4. McLean E et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr, 2009, 12(4): 444-454.
5. Milman N. Prepartum anaemia: prevention and treatment. Ann Hematol, 2008, 87: 949–959.
6. Виноградова M.А., Федорова Т.А. Железодефицитная анемия во время беременности – профилактика и лечение. Медицинский совет, 2015, 9: 78-82.
7. Breymann C. et al. Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region. Journal of perinatal medicine, 2011, 39(2): 113-121.
8. The Obstetric Hematology Manual edited by Sue Pavord, Beverley Hunt. Cambridge University Press, 2010: 13-27.
9. Arnold DL, Williams MA, Miller RS, Qiu C & Sorensen TK. Maternal iron deficiency anaemia is associated with an increased risk of abruption placentae – a retrospective case control study. J Obstet Gynaecol Res, 2009, 35, 446-452.
10. Allen LH. Biological mechanisms that might underlie iron’s effects on fetal growth and preterm birth. Am J Clin Nutr, 2001, 131: 581S–9S.
11. Scholl TO and Reilly T Anemia, Iron and Pregnancy Outcome. Am J Clin Nutr, 2000, 130: 443S–447S.
12. Beard JL. Why iron deficiency is important in infant development. J Nutr, 2008, 138: 2534-2536.
13. Виноградова М.А., Федорова Т.А., Рогачевский О.В. Влияние железодефицитной анемии на исходы беременности. Акушерство и гинекология, 2015, 7: 78-82.
14. Breymann C et al. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Archives of gynecology and obstetrics, 2010, 282(5): 577-580.
15. Баранов И.И., Дегтярева Е.И., Апресян С.В. Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии, 3-е изд. М., 2016.
16. Моисеев С.В. Железа карбоксимальтозат (Феринжект) – новый внутривенный препарат для лечения железодефицитной анемии. Клин фармакол тер, 2012, 21(2): 48-53.
17. Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program, 2010, 2010(1): 338-47.
18. Moore R, Gaskell H, Rose P, Allan J. Metaanalysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. BMC Blood Disord, 2011, 1: 4.
19. Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med, 2012, 40(5): 469-74.
20. Breymann C, Milman N, Mezzacasa A, Bernard R and Dudenhausen J, on behalf of the FER-ASAP investigators Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, openlabel, randomized controlled trial (FER-ASAP). J Perinat Med, 2016, Jun 8. pii: /j/jpme.ahead-ofprint/jpm-2016-0050/jpm-2016-0050.xml. doi: 10.1515/jpm-2016-0050.
21. Froessler B. et al. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC pregnancy and childbirth, 2014, 14(1): 115.
22. Breymann C et al. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International Journal of Gynecology & Obstetrics, 2008, 101(1): 67-73.
23. Виноградова М.А. Карбоксимальтозат железа в лечении анемии в акушерско-гинекологической практике. Клиническая фармакология и терапия, 2014, 23(4): 36-40.
24. Vinogradova MA, Fedorova TA, Strelnikova EV et al. Anemia during the Pregnancy: The Management and Outcomes Depending on the Etiology Blood, 2014, 56th ASH Annual Meeting Abstracts, December 6-9, 2014, San Francisco, California. Blood, 2014, 124: 4830.
25. Vinogradova MA, Fedorova TA, Rogachevsky OV. Iron deficiency anemia during pregnancy: the treatment approaches and outcomes. British Journal of Haematology, 2015, 169(suppl 1): 100-101.
26. Шевелева Г.А., Федорова Т.А., Дубровина Н.В., Сокур Т.Н., Бакуридзе Э.М. Нарушение вегетативной регуляции у беременных с железодефицитной анемией и способы ее коррекции. Акушерство и гинекология, 2017, 6: 35-40.
27. Радзинский В.Е., Ордиянц И.М., Побединская О.С. Железодефицитная анемия как фактор риска плацентарной недостаточности и перинатальных осложнений. Акушерство и гинекология, 2016, 12: 125-130.
Review
For citations:
Vinogradova MA. IRON-DEFICIENCY ANEMIA IN PREGNANCY: PECULIARITIES OF THERAPY. Meditsinskiy sovet = Medical Council. 2017;(20):194-197. (In Russ.) https://doi.org/10.21518/2079-701X-2017-20-194-197
Views:
970
Email this article 